<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>TMX Newsfile Chemical News Releases</title>
		<link>https://feeds.newsfilecorp.com/industry/chemical</link>
		<description>Last 10 Chemical news releases from TMX Newsfile. Contact us for a custom full-bodied RSS feed complete with exchange and ticker data.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Fri, 05 Jun 2026 08:00:40 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/tmx-newsfile-wire-logo.png</url>
			<title>TMX Newsfile Chemical News Releases</title>
			<link>https://feeds.newsfilecorp.com/industry/chemical</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/industry/chemical"/>
		<item xml:lang="en">
			<title>Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award</title>
			<link>https://www.newsfilecorp.com/release/300261/Telescope-Innovations-Founder-and-CTO-Professor-Jason-Hein-Receives-2026-SCI-Canada-LeSueur-Memorial-Award</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/300261/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason HeinTo view an enhanced version of this graphic, please...</description>
			<pubDate>Fri, 05 Jun 2026 08:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/300261/Telescope-Innovations-Founder-and-CTO-Professor-Jason-Hein-Receives-2026-SCI-Canada-LeSueur-Memorial-Award</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company</title>
			<link>https://www.newsfilecorp.com/release/299526/Telescope-Innovations-Secures-Third-SelfDriving-Lab-Deployment-with-Major-Global-Pharmaceutical-Company</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/299526/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, today announced that is has signed  an agreement with a major global pharmaceutical company to deliver a Self-Driving Lab (SDL) platform at the company's European operations. The deployment, Telescope's third SDL placement in its 2026 fiscal...</description>
			<pubDate>Mon, 01 Jun 2026 08:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/299526/Telescope-Innovations-Secures-Third-SelfDriving-Lab-Deployment-with-Major-Global-Pharmaceutical-Company</guid>
			<atom:subtitle>Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>TMC Group Commissions New Capacity to Support Next-Generation Radiotheranostics</title>
			<link>https://www.newsfilecorp.com/release/298332/TMC-Group-Commissions-New-Capacity-to-Support-NextGeneration-Radiotheranostics</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/298332/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - As demand for radiotheranostics continues to grow exponentially, TMC Group, a Canadian manufacturer of high-purity enriched stable isotopes, is commissioning new production lines this year. This will add 50 percent more capacity to help ensure reliable supply for radiopharmaceutical research, clinical development, and future commercialization.TMC Group will be exhibiting at the 2026 Society of Nuclear Medicine and Molecular Imaging...</description>
			<pubDate>Thu, 21 May 2026 10:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/298332/TMC-Group-Commissions-New-Capacity-to-Support-NextGeneration-Radiotheranostics</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Shares Spring 2026 Conference and Events Lineup</title>
			<link>https://www.newsfilecorp.com/release/296847/Telescope-Innovations-Shares-Spring-2026-Conference-and-Events-Lineup</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/296847/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lectures on our advanced...</description>
			<pubDate>Mon, 11 May 2026 08:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/296847/Telescope-Innovations-Shares-Spring-2026-Conference-and-Events-Lineup</guid>
			<atom:subtitle>The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Bachem Announces Changes to the Corporate Executive Committee</title>
			<link>https://www.newsfilecorp.com/release/295942/Bachem-Announces-Changes-to-the-Corporate-Executive-Committee</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/295942/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Bubendorf, Switzerland--(Newsfile Corp. - May 5, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue a new opportunity outside the company. Until a successor will be      appointed, Anne-Kathrin Stoller will assume the role of Chief Commercial Officer in addition to her responsibilities as Chief Executive Officer (CEO), effective May 25, 2026.              “Torsten Wöhr has made a big contribution to the development...</description>
			<pubDate>Tue, 05 May 2026 01:08:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/295942/Bachem-Announces-Changes-to-the-Corporate-Executive-Committee</guid>
		</item>
		<item xml:lang="en">
			<title>Bachem Annual General Meeting 2026</title>
			<link>https://www.newsfilecorp.com/release/294924/Bachem-Annual-General-Meeting-2026</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/294924/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;      All proposals of the Board of Directors approved.            Dividend of CHF 0.90 per share.                Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the      74‘977‘940 eligible shares were present.      The Annual General Meeting approved a dividend of CHF 0.90 per share. The dividend will be paid on May...</description>
			<pubDate>Wed, 29 Apr 2026 12:09:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/294924/Bachem-Annual-General-Meeting-2026</guid>
		</item>
		<item xml:lang="en">
			<title>Bachem Secures Financing of Strategic Growth Initiatives</title>
			<link>https://www.newsfilecorp.com/release/294334/Bachem-Secures-Financing-of-Strategic-Growth-Initiatives</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/294334/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;                                                                    Media Release                      Bubendorf, Switzerland--(Newsfile Corp. - April 27, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today the closing of a revolving credit facility of CHF 500 million with a maturity of five years and a non-committed option to increase the      facility by CHF 150 million.              The revolving credit facility was syndicated with UBS Switzerland AG acting as lead arranger and...</description>
			<pubDate>Mon, 27 Apr 2026 01:03:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/294334/Bachem-Secures-Financing-of-Strategic-Growth-Initiatives</guid>
		</item>
		<item xml:lang="en">
			<title>ColdBlock Technologies Inc. Announces Exclusive Distribution Partnership with Minas y Concentradoras S.A. in Peru</title>
			<link>https://www.newsfilecorp.com/release/293674/ColdBlock-Technologies-Inc.-Announces-Exclusive-Distribution-Partnership-with-Minas-y-Concentradoras-S.A.-in-Peru</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/293674/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Niagara Falls, Ontario--(Newsfile Corp. - April 22, 2026) - ColdBlock Technologies Inc. (ColdBlock), developer of innovative sample digestion technology, is proud to announce a new partnership with Minas y Concentradoras S.A., a leading laboratory equipment distributor headquartered in Peru.This collaboration marks an important step in ColdBlock's continued expansion in Latin America, bringing its advanced sample digestion solutions to laboratories, researchers, and industry leaders across the...</description>
			<pubDate>Wed, 22 Apr 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/293674/ColdBlock-Technologies-Inc.-Announces-Exclusive-Distribution-Partnership-with-Minas-y-Concentradoras-S.A.-in-Peru</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026</title>
			<link>https://www.newsfilecorp.com/release/292312/Telescope-Innovations-Provides-Financial-Results-of-Second-Fiscal-Quarter-2026</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/292312/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of...</description>
			<pubDate>Mon, 13 Apr 2026 18:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/292312/Telescope-Innovations-Provides-Financial-Results-of-Second-Fiscal-Quarter-2026</guid>
			<atom:subtitle>Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation</title>
			<link>https://www.newsfilecorp.com/release/289035/Telescope-Innovations-Announces-Expansion-of-Consulting-Role-for-Dr.-Joel-M.-Hawkins-Industry-Leader-in-Process-Chemistry-Automation</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/289035/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows and enabling the...</description>
			<pubDate>Mon, 23 Mar 2026 08:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/289035/Telescope-Innovations-Announces-Expansion-of-Consulting-Role-for-Dr.-Joel-M.-Hawkins-Industry-Leader-in-Process-Chemistry-Automation</guid>
		</item>
	</channel>
</rss>
